Location History:
- New York, NY (US) (2003 - 2009)
- New Brunswick, NJ (US) (2009)
- Brantford, CT (US) (2014 - 2017)
- Branford, CT (US) (2001 - 2023)
Company Filing History:
9 out of 512 
8 out of 1,455 
5 out of 484 
Years Active: 2001-2023
Title: Joseph R. Bertino: Pioneering Innovations in Cancer Treatment
Introduction
Joseph R. Bertino, located in Branford, CT (US), is a prominent inventor with an impressive portfolio of 21 patents. His work primarily focuses on advanced cancer treatment methodologies, contributing significantly to the field of oncology and improving therapeutic strategies for patients suffering from aggressive malignancies.
Latest Patents
One of his notable patents is titled "Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moieties." This invention involves anti-matriptase antibodies and their immunoconjugates with cytotoxic agents. It aims to effectively kill or inhibit the growth of matriptase-expressing cancer cells, especially in multiple myeloma and breast cancer. The remarkable aspect of this invention is the demonstrated lack of toxicity or significant weight loss in test animals, indicating a safe delivery mechanism for potent anticancer agents.
Additionally, another influential patent of Bertino's is titled "Use of multi-frequency impedance cytometry in conjunction with machine learning for classification of biological particles." This patent describes an innovative approach to classify biological particles such as blood cells and circulating tumor cells (CTCs) using multi-frequency impedance cytometry combined with supervised machine learning, showing enhanced accuracy in classification processes.
Career Highlights
Bertino has held distinguished positions at leading research institutions, including the Sloan Kettering Institute for Cancer Research and Rutgers, the State University of New Jersey. His long-standing commitment to cancer research has led to substantial advancements in therapeutic techniques that can potentially enhance patient outcomes.
Collaborations
Throughout his career, Bertino has collaborated with notable professionals in the field, including Debabrata Banerjee and Siang-Yo Lin. These collaborations have contributed to the development of innovative cancer treatments and the advancement of research methodologies in biotechnology.
Conclusion
Joseph R. Bertino stands out as a significant figure in cancer research and treatment innovation. With 21 patents to his name and a passion for developing effective cancer therapies, his contributions will undoubtedly have lasting effects on medical science and patient care. His work exemplifies the intersection of innovation and healthcare, paving the way for more effective solutions in the fight against cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.